Insiders · Profile

Hamm Robert A

Chief Operating Officer at Biogen. Filing since 13 Feb 2007. CIK 0001335018

Company
Date
Role
Action
Shares
Amount
Of holding
23 Apr 2010
Chief Operating Officer
Sold, plan not stated
5,668
$295.83K
17.2%
18 Feb 2010
Chief Operating Officer
Sold, plan not stated
6,581
$369.56K
22.3%
4 Nov 2009
Chief Operating Officer
Sold, plan not stated
2,854
$122.17K
8.0%
22 Jun 2009
Chief Operating Officer
Sold, plan not stated
3,194
$159.91K
7.8%
19 Feb 2009
EVP, Pharma. Oper. & Tech.
Sold, plan not stated
3,412
$173.67K
11.0%
11 Feb 2009
EVP, Pharma. Oper. & Tech.
Sold, plan not stated
3,670
$186.28K
9.7%
6 Nov 2008
EVP, Pharma. Oper. & Tech.
Sold, plan not stated
2,855
$127.25K
7.7%
22 Jul 2008
EVP, Pharma. Oper. & Tech.
Sold, plan not stated
156,086
$10.93M
80.0%
15 Apr 2008
EVP, Pharma. Oper. & Tech.
Sold, plan not stated
3,413
$217.80K
8.0%
12 Feb 2008
EVP, Pharma. Oper. & Tech.
Sold, plan not stated
3,679
$224.10K
11.5%
23 Apr 2007
SVP, Neurology SBU
Sold, plan not stated
3,731
$176.63K
19.6%
20 Mar 2007
SVP, Immunology Business Unit
Sold, plan not stated
5,077
$225.82K
21.1%
13 Feb 2007
SVP, Immunology Business Unit
Sold, plan not stated
6,188
$304.55K
24.5%
13 decisions on file.